Steven Love
Known title: DirectorCIK: 0001410466
Steven Love's purchase track record
Steven Love has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/14/2025 | OABI | $37K | +34.9% | +3.3% | +16.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OABI | ▲ Buy | Option Exercise | 20,000 | — | 6/17/2026 | View on chart |
| OABI | ▲ Buy | Option Exercise | 13,333 | — | 11/1/2025 | View on chart |
| OABI | ▲ Buy | Option Exercise | 20,000 | — | 6/17/2025 | View on chart |
| OABI | ▲ Buy | Open Market | 25,000 | $37K | 5/14/2025 | View on chart |
| OABI | ▲ Buy | Option Exercise | 13,333 | — | 11/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
OmniAb (OABI) Shares Analyst/Investor Day Slideshow
OmniAb released a slideshow from its recent Analyst/Investor Day on Seeking Alpha. The presentation offered updates on the company's pipeline and strategic plans. The material provides investors with additional detail that may influence expectations, especially as the stock trades near its recent support level of $1.48 and below the average analyst target of $8.40.
OmniAb (OABI) Shares Analyst/Investor Day Slideshow. OmniAb released a slideshow from its recent Analyst/Investor Day on Seeking Alpha. The presentation offered updates on the company's pipeline and strategic plans. The material provides investors with additional detail that may influence expectations, especially as the stock trades near its recent support level of $1.48 and below the average analyst target of $8.40.